Potential drug targets for ALS and FTD identified in two studies
A pair of collaborative studies led by Fen-Biao Gao, Ph.D., have identified two potential drug targe...
Historically ‘safer’ tramadol more likely than other opioids to result in prolonged use
Surgical patients receiving the opioid tramadol ha...
Research into opioid painkillers could provide clues for safer drug development
Researchers have taken a step closer to understand...
Urovant Sciences Announces Positive Topline Results from Pivotal Phase 3 EMPOWUR Study of Vibegron in Patients with Overactive Bladder
IRVINE, Calif. & BASEL, Switzerland–(BUS...
FDA warns Americans not to buy drugs from Canadian company
(HealthDay)—A large Canadian drug distributor se...
FDA warns 17 companies about illegal Alzheimer disease products
(HealthDay)—A number of warning/advisory letters...
FDA approves cablivi for rare blood-clotting disorder
(HealthDay)—Cablivi (caplacizumab-yhdp) injectio...
How gut bacteria affect the treatment of Parkinson’s disease
Patients with Parkinson’s disease are treate...
Opioid prescriptions almost twice as likely for rural vs. urban Americans
(HealthDay)—As the United States battles an epid...
